These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 39163894)

  • 1. Metabolomics and serum pharmacochemistry combined with network pharmacology uncover the potential effective ingredients and mechanisms of Yin-Chen-Si-Ni Decoction treating ANIT-induced cholestatic liver injury.
    Liu Y; Chen H; Yang G; Feng F
    J Ethnopharmacol; 2024 Dec; 335():118713. PubMed ID: 39163894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats.
    Wang M; Liu F; Yao Y; Zhang Q; Lu Z; Zhang R; Liu C; Lin C; Zhu C
    J Ethnopharmacol; 2021 Apr; 270():113816. PubMed ID: 33444723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation into the anti-inflammatory mechanism of Pothos chinensis (Raf.) Merr. By regulating TLR4/MyD88/NF-κB pathway: Integrated network pharmacology, serum pharmacochemistry, and metabolomics.
    Xiao G; Yang M; Zeng Z; Tang R; Jiang J; Wu G; Xie C; Jia D; Bi X
    J Ethnopharmacol; 2024 Nov; 334():118520. PubMed ID: 38964626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of the toxicity-related quality markers and mechanisms of Zhi-Zi-Hou-Po decoction based on Chinmedomics combined with differentially absorbed components and network pharmacology.
    Wan S; Xie X; Yang G; Feng F
    J Ethnopharmacol; 2024 Feb; 320():117408. PubMed ID: 37972910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating serum pharmacochemistry, network pharmacology and untargeted metabolomics strategies to reveal the material basis and mechanism of action of Feining keli in the treatment of chronic bronchitis.
    Zhu Z; Feng YD; Zou YL; Xiao YH; Wu JJ; Yang YR; Jiang XX; Wang L; Xu W
    J Ethnopharmacol; 2024 Dec; 335():118643. PubMed ID: 39089660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metabolomics study on the mechanisms of Gardeniae fructus against α-naphthylisothiocyanate-induced cholestatic liver injury.
    Cao Y; Li S; Zhang Z; Zeng M; Zheng X; Feng W
    Biomed Chromatogr; 2024 Oct; 38(10):e5961. PubMed ID: 39054754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UPLC-MS-based metabonomic analysis of intervention effects of Da-Huang-Xiao-Shi decoction on ANIT-induced cholestasis.
    Zhu G; Feng F
    J Ethnopharmacol; 2019 Jun; 238():111860. PubMed ID: 30965080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated network analysis and metabolomics reveal the molecular mechanism of Yinchen Sini decoction in CCl
    Zheng W; Shi C; Meng Y; Peng J; Zhou Y; Pan T; Ning K; Xie Q; Xiang H
    Front Pharmacol; 2023; 14():1221046. PubMed ID: 37818184
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolomics analysis delineates the therapeutic effects of Huangqi decoction and astragalosides on α-naphthylisothiocyanate (ANIT) -induced cholestasis in rats.
    Qiu J; Yan J; Liu W; Liu X; Lin J; Du Z; Qi L; Liu J; Xie G; Liu P; Wang X
    J Ethnopharmacol; 2021 Mar; 268():113658. PubMed ID: 33307056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics combined with network pharmacology to study the mechanism of Shentong Zhuyu decoction in the treatment of rheumatoid arthritis.
    Jiang Y; Zheng Y; Dong Q; Liao W; Pang L; Chen J; He Q; Zhang J; Luo Y; Li J; Fu C; Fu Q
    J Ethnopharmacol; 2022 Mar; 285():114846. PubMed ID: 34826542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A UPLC-MS/MS-based metabolomics analysis of the pharmacological mechanisms of rabdosia serra against cholestasis.
    Zhang K; Yao Y; Wang M; Liu F; Wang Q; Ma H; Xie Y; Ma Y; Dai P; Zhu C; Lin C
    Phytomedicine; 2021 Oct; 91():153683. PubMed ID: 34364160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated serum pharmacochemistry, network pharmacology, and pharmacokinetics to clarify the effective components and pharmacological mechanisms of the proprietary Chinese medicine Jinkui Shenqi Pill in treating kidney yang deficiency syndrome.
    Gao J; Xu E; Wang H; Wang L; Chen S; Wang C; Meng F
    J Pharm Biomed Anal; 2024 Sep; 247():116251. PubMed ID: 38820836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yinchenzhufu decoction protects against alpha-naphthylisothiocyanate-induced acute cholestatic liver injury in mice by ameliorating disordered bile acid homeostasis and inhibiting inflammatory responses.
    Wang GF; Li YY; Shi R; Wang TM; Li YF; Li WK; Zheng M; Fan FB; Zou J; Zan B; Wu JS; Ma YM
    J Ethnopharmacol; 2020 May; 254():112672. PubMed ID: 32084553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncovering the mechanisms of Zhubi decoction against rheumatoid arthritis through an integrated study of network pharmacology, metabolomics, and intestinal flora.
    Liu J; Li B; Zhou X; Liu G; Li C; Hu Z; Peng R
    J Ethnopharmacol; 2025 Jan; 336():118736. PubMed ID: 39186991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zhisou powder displays therapeutic effect on chronic bronchitis through inhibiting PI3K/Akt/HIF-1α/VEGFA signaling pathway and reprograming metabolic pathway of arachidonic acid.
    Dong Y; Liu Y; Tang J; Du J; Zhuang X; Tan S; Yang Y; Yin D
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117110. PubMed ID: 37673198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated serum pharmacochemistry and network pharmacological analysis used to explore possible anti-rheumatoid arthritis mechanisms of the Shentong-Zhuyu decoction.
    Wang L; Pu X; Nie X; Wang D; Jiang H; Chen Y; Pang L; Wang S; Wang X; Xu Z; Fu C; Lin D; Zhang J
    J Ethnopharmacol; 2021 Jun; 273():113988. PubMed ID: 33667569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the effect and mechanism of cucurbitacin B on cholestatic liver injury based on network pharmacology and experimental verification.
    Dai S; Wu R; Fu K; Li Y; Yao C; Liu Y; Zhang F; Zhang S; Guo Y; Yao Y; Li Y
    J Ethnopharmacol; 2024 Mar; 322():117584. PubMed ID: 38104874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rg1 alleviates ANIT-induced cholestatic liver injury by inhibiting hepatic inflammation and oxidative stress via SIRT1 activation.
    Gao Q; Li G; Zu Y; Xu Y; Wang C; Xiang D; He W; Shang T; Cheng X; Liu D; Zhang C
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117089. PubMed ID: 37634749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated 16 S rRNA gene sequencing and serum metabolomics approaches to decipher the mechanism of Qingre Lidan decoction in the treatment of cholestatic liver injury.
    Chang Y; Xia Y; Liu X; Yu P; Fan F; Shi Y; Yan S; Yan S
    J Pharm Biomed Anal; 2023 Sep; 234():115535. PubMed ID: 37390604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the pharmacodynamic substances and possible mechanism of Trichosanthis Pericarpium in the treatment of coronary heart disease based on plasma pharmacochemistry, network pharmacology and experimental validation.
    Zhang XY; Xia KR; Wang YN; Liu P; Shang EX; Liu CY; Liu YP; Qu D; Li WW; Duan JA; Chen Y; Zhang HQ
    J Ethnopharmacol; 2024 May; 325():117869. PubMed ID: 38342153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.